PAD Awareness Study
Gaps In Awareness of Peripheral Arterial Disease in Hong Kong: A Cross Sectional Study
1 other identifier
observational
1,000
1 country
1
Brief Summary
Peripheral arterial disease (PAD) is one of the most common cardiovascular diseases in developed countries \[1\] and is an emerging problem in developing countries \[2, 3\]. The prevalence of PAD in European population studies ranged from 3.6 to 9.2 % and 10-20 % in those aged over 70 years \[4\]. In a recent meta-analysis, the prevalence of PAD in China increased gradually by age until mid-60s, after which the increase accelerated. In the early stages, PAD is mostly silent. With the progression of disease, it may manifest as intermittent claudication, pain at rest, non-healing ulcer and gangrene resulting in lower-extremity amputation \[5\]. PAD is a major cause of disability, loss of employment, and lifestyle changes, and is a marker for systemic atherosclerotic diseases. Patients with symptomatic PAD have at least a 30% risk of death within 5 years rising to almost 50% within 10 years, resulting primarily from myocardial infarction or stroke \[4\]. Despite the major health risks associated with PAD, it is generally not recognized by clinicians or the general public in comparison with other cardiovascular diseases. However, asymptomatic individuals also have higher risk of adverse cardiovascular events similar to those with symptomatic PAD \[6\]. Many studies have shown that public awareness of PAD is much lower than that of other diseases. It has been reported that awareness of PAD ranged from 20 to 36 %, whereas awareness of other common diseases was more than 60 % in the same population \[6-9\]. Awareness is important for patients and physicians, and the need for public awareness programs has been highlighted \[10, 11\]. There is paucity of published literature on public awareness of PAD in Asian countries. It is difficult to reduce the morbidity and mortality of untreated PAD without adequate public awareness of PAD and its risk factors and consequences \[7\]. Insights into public awareness of PAD will help in developing strategies for behavioral change communication and health promotion. In this study we aimed to assess awareness of PAD among adults in Hong Kong. The survey is designed to measure knowledge of factors that increase the risk for PAD and the clinical risk consequences of having PAD. These data will provide useful information to guide future local public cardiovascular educational efforts.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 21, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 28, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
August 28, 2020
CompletedFirst Submitted
Initial submission to the registry
March 23, 2021
CompletedFirst Posted
Study publicly available on registry
September 23, 2022
CompletedSeptember 23, 2022
September 1, 2022
7 months
March 23, 2021
September 20, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Participants' awareness of PAD
Awareness of PAD among adults in Hong Kong will be measured by questionnaire
7 months
Interventions
Patients will be asked to show their consultation slip to confirm they attend to clinic on the day. The will also be asked to show their HKID card to comfirm they are aged 40 or above. The purpose of the study will be explained. If patient agrees to proceed, he/she will be given a self-administered questionniare. An interviewer-administered questionnaire will be provided for subjects who have poor sightedness or are illiterate. Since only anonymous data and no identifiable information will be collected, participants cannot be identified from the questionnaire. Therefore, inform consent will not be obtained.
Eligibility Criteria
A sample size of 1000 is associated with a margin of error of less than 4.5% and a confidence level of 95%. The study population is weighted by age (into three 20-year categories: 40 to 59, 60 to 79 and ≥80 years of age) and on gender to reflect Hong Kong census estimates for 2016.
You may qualify if:
- Age 40 or above
- Patients who attend outpatient clinics at the Prince of Wales Hospital
You may not qualify if:
- Vulnerable subjects that are illiterate and have severe hearing impairment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Prince of Wales Hospital
Shatin, New Territories, Hong Kong
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
March 23, 2021
First Posted
September 23, 2022
Study Start
January 21, 2020
Primary Completion
August 28, 2020
Study Completion
August 28, 2020
Last Updated
September 23, 2022
Record last verified: 2022-09
Data Sharing
- IPD Sharing
- Will not share